Meloxicam Stada (Meloxicam)

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

• Osteoarthritis: helps decrease joint pain and improve mobility.
• Rheumatoid arthritis: reduces inflammatory swelling and pain in affected joints.
• Ankylosing spondylitis: alleviates spinal stiffness and chronic back pain.
• Acute pain: provides short‑term relief for moderate to severe pain episodes.

• Meloxicam selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, pain, and fever while sparing COX‑1 activity that protects gastric mucosa and platelet function.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Peripheral edema: swelling of the lower limbs.
• Elevated liver enzymes: mild, transient changes in laboratory tests.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiovascular events: increased risk of heart attack or stroke.
• Renal impairment: reduced kidney function or acute renal failure.
• Hepatotoxicity: significant liver injury with jaundice.

Before prescribing Meloxicam, clinicians should evaluate patient history and comorbidities.

• Cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension.
• Gastrointestinal safety: use cautiously in those with a history of ulcers or bleeding.
• Renal function: monitor serum creatinine in patients with existing kidney disease.
• Hepatic health: assess liver enzymes periodically, especially in patients with liver disease.
• Pregnancy and lactation: avoid unless the potential benefit justifies the risk, as safety data are limited.
• Store at ambient temperature: keep below 25 °C, retain in the original container, and protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
• Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients.

• Diuretics: potential for decreased kidney perfusion.
• Lithium: NSAIDs can raise lithium serum levels, requiring monitoring.